Victrex (LON:VCT) Downgraded to Hold Rating by Deutsche Bank Aktiengesellschaft

Victrex (LON:VCT - Get Free Report) was downgraded by stock analysts at Deutsche Bank Aktiengesellschaft to a "hold" rating in a research note issued to investors on Tuesday, Marketbeat reports. They presently have a GBX 850 ($11.56) target price on the stock, down from their prior target price of GBX 990 ($13.46). Deutsche Bank Aktiengesellschaft's target price suggests a potential upside of 18.22% from the company's previous close.

Separately, JPMorgan Chase & Co. reduced their target price on Victrex from GBX 940 ($12.78) to GBX 818 ($11.12) and set a "neutral" rating on the stock in a report on Wednesday.

Victrex Price Performance

LON VCT traded down GBX 1 ($0.01) during trading on Tuesday, reaching GBX 719 ($9.77). 252,492 shares of the company traded hands, compared to its average volume of 418,969. The company has a debt-to-equity ratio of 10.93, a quick ratio of 1.99 and a current ratio of 4.39. The stock's 50 day moving average price is GBX 800.54 and its two-hundred day moving average price is GBX 894.36. The company has a market cap of £627.20 million, a price-to-earnings ratio of 20.43, a P/E/G ratio of 1.92 and a beta of 0.69. Victrex has a 1-year low of GBX 667.62 ($9.08) and a 1-year high of GBX 1,160 ($15.77).

Victrex (LON:VCT - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.31) EPS for the quarter. Victrex had a return on equity of 6.67% and a net margin of 10.81%. As a group, analysts anticipate that Victrex will post 73.1078905 EPS for the current year.

Insider Buying and Selling at Victrex

In related news, insider Dame Vivienne Cox purchased 2,747 shares of Victrex stock in a transaction dated Tuesday, July 8th. The shares were acquired at an average cost of GBX 721 ($9.80) per share, for a total transaction of £19,805.87 ($26,924.78). Also, insider David Thomas purchased 1,158 shares of Victrex stock in a transaction dated Tuesday, May 13th. The stock was bought at an average price of GBX 846 ($11.50) per share, for a total transaction of £9,796.68 ($13,317.94). 1.64% of the stock is owned by company insiders.

About Victrex

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.